Related Experiment Video
Updated: Aug 17, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
Narrow-band UVB for the treatment of generalized vitiligo in children
1Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. ajkanwar@sify.com
Insights
Narrow-band ultraviolet B (UVB) therapy is effective for childhood vitiligo, offering significant repigmentation in 75% of patients within a year. This treatment is well-tolerated, with mild, temporary side effects, making it a viable option for pediatric cases.
Area of Science:
- Dermatology
- Phototherapy
- Pediatric Medicine
Background:
- Vitiligo commonly affects children, with onset often before age 20.
- Existing treatments for pediatric vitiligo have limited efficacy and poor response rates.
Purpose of the Study:
- To assess the effectiveness and safety of narrow-band UVB therapy for generalized vitiligo in children.
- To determine the treatment duration and response rates for pediatric vitiligo patients.
Main Methods:
- Twenty-six children (ages 5-14) with generalized vitiligo (≥5% skin depigmentation) received narrow-band UVB therapy three times weekly for up to one year.
- Repigmentation levels (marked, moderate, mild, none) were evaluated after one year of treatment.
Main Results:
- Fifteen out of 20 (75%) patients who completed the study achieved marked to complete repigmentation.
- Four patients (20%) showed moderate repigmentation, and one (5%) showed mild repigmentation.
- An average of 34 treatment visits were needed for 50% repigmentation; adverse events were mild and transient.
Conclusions:
- Narrow-band UVB therapy is an effective and well-tolerated treatment for generalized vitiligo in children.
- The study supports the use of narrow-band UVB as a valuable therapeutic option for pediatric vitiligo.
- Further research may explore long-term efficacy and optimal treatment protocols.
Abstract:
Vitiligo usually begins in childhood with approximately half of the patients manifesting onset of disease prior to the age of 20 years. Treatment options in this age group are few and have disappointing response rates. This study was designed to evaluate the role of narrow-band UVB in the treatment of generalized vitiligo in children. Twenty-six children (aged 5-14 years) with generalized vitiligo (minimal extent of depigmentation of 5% of the skin) were treated three times per week with narrow-band UVB therapy for a maximum period of 1 year. Of 26 patients, 6 were lost to follow up and 20 (7 males, 13 females) completed the study. At the end of 1 year of therapy, 15 (75%) patients developed marked to complete repigmentation. Moderate and mild repigmentation was noted in four (20%) and one (5%) patients, respectively. An average number of 34 (+/- 2) treatment visits was required to achieve 50% repigmentation. Adverse events were mild and transient. Narrow-band UVB is an effective and well-tolerated treatment option for childhood vitiligo.
More Related Videos
Related Concept Videos
Acne Infection
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
